Trial intelligence / Profile preview

Heme arginate induction of HO-1 in metabolic syndrome

NL-OMON34409Phase 2Active, not recruiting

Sponsor
Radboud University Medical Center
Start
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of heme arginate, sponsored by Radboud University Medical Center. Started Sep 2010; status: active, not recruiting.

02

Drugs

heme arginate

Beyond the preview

Go deeper on NL-OMON34409.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON34409.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call